Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Dr Reddys Laboratories gets adverse ruling in US over patent infringement case

      Dr Reddy's Laboratories gets adverse ruling in US over patent infringement case

      supriya kashyap kashyap17 Feb 2017 12:25 PM IST
      New Delhi : Drug major Dr Reddy's Laboratories said it has received an unfavourable ruling in a US court regarding a patent infringement case over...
      Europe ready to embrace first copies of biotech cancer drugs

      Europe ready to embrace first copies of biotech cancer drugs

      supriya kashyap kashyap17 Feb 2017 12:25 PM IST
      London : Treatment with two important cancer drugs is about to get much cheaper in Europe with a cut-price copy of Roche's blood cancer drug Rituxan...
      USFDA Accepts BLA for Mylan and Biocons Proposed Biosimilar Pegfilgrastim for Review

      USFDA Accepts BLA for Mylan and Biocon's Proposed Biosimilar Pegfilgrastim for Review

      supriya kashyap kashyap17 Feb 2017 12:24 PM IST
      Bengaluru : Mylan N.V. and Biocon Ltd. announced that the U.S. Food and Drug Administration (FDA) has accepted Mylan's Biologics License Application...
      Lupin gets USFDA nod for generic cough relief oral solution

      Lupin gets USFDA nod for generic cough relief oral solution

      supriya kashyap kashyap17 Feb 2017 12:24 PM IST
      New Delhi : Drug firm Lupin has received approval from the US health regulator for generic Hydrocodone Bitartrate and Homatropine Methylbromide oral...
      FDA approves new psoriasis drug

      FDA approves new psoriasis drug

      supriya kashyap kashyap16 Feb 2017 11:12 AM IST
      The U.S. Food and Drug Administration approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq is administered as...
      Dr Reddys, Aurobindo recall drugs from US market

      Dr Reddy's, Aurobindo recall drugs from US market

      supriya kashyap kashyap16 Feb 2017 10:58 AM IST
      Hyderabad : Drug firms Dr Reddy's Laboratories Limited and Aurobindo Pharma Limited have separately started recalling few quantities of two different...
      VIVO Healthcare Received Investment from ICCO of Netherlands

      VIVO Healthcare Received Investment from ICCO of Netherlands

      supriya kashyap kashyap16 Feb 2017 10:46 AM IST
      Haryana : VIVO Healthcare announced that it has received a strategic investment from ICCO Investments, the investment arm of Netherlands based ICCO...
      AiMeD wants govt to mandate Buy in India for devices with 50 percent price benefit for Indian products

      AiMeD wants govt to mandate Buy in India for devices with 50 percent price benefit for Indian products

      supriya kashyap kashyap16 Feb 2017 10:43 AM IST
      Association of Indian Medical Device Industry (AiMeD) is of the view that since the government health departments are the largest purchaser of medical...
      Fortis Healthcare Q3 net profit at Rs 453.29 crores

      Fortis Healthcare Q3 net profit at Rs 453.29 crores

      supriya kashyap kashyap15 Feb 2017 11:13 AM IST
      New Delhi : Fortis Healthcare reported a net profit of Rs 453.29 crore for the third quarter ended December 31, 2016-17.The company had reported net...
      Bajaj Allianz General Insurance launches Health Guard insurance policy

      Bajaj Allianz General Insurance launches Health Guard insurance policy

      supriya kashyap kashyap15 Feb 2017 11:09 AM IST
      Mumbai : Private sector non-life insurer, Bajaj Allianz General Insurance said it has launched its redesigned comprehensive health insurance policy...
      Piramal Enterprises Limited Consolidated Results for the Q3 and 9M FY2017

      Piramal Enterprises Limited Consolidated Results for the Q3 and 9M FY2017

      supriya kashyap kashyap15 Feb 2017 11:09 AM IST
      Mumbai : Piramal Enterprises Limited (‘PEL’, NSE: PEL, BSE: 500302) today announces its consolidated results for the Q3 and 9M FY2017.Q3 & 9M...
      Gilead challenges GSK with strong HIV drug data

      Gilead challenges GSK with strong HIV drug data

      supriya kashyap kashyap15 Feb 2017 10:32 AM IST
      Gilead Sciences has thrown down a challenge to GlaxoSmithKline with good clinical trial results for an experimental HIV drug that works in the same...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok